$360B Women's Health Ghost Market Report

The Ghost Market Report shines a spotlight on the massive, yet overlooked opportunities within women's health—a space we've termed the "Ghost Market." It explores critical healthcare gaps affecting millions of women, highlighting where current solutions are insufficient or entirely absent. Our analysis identifies key areas ripe for innovation and investment, aiming to direct funding and attention toward impactful novel solutions in women's health.

Please complete the form below to receive this Ghost Market Report:

I have read and accept the privacy policy

By registering for this white paper, you accept that you may receive direct communication from Amboy St. Ventures. We will not share your email address with third parties.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

The Underserved Market: Menopause

Amboy Street Ventures’ Underserved Market series breaks down the history, developments and opportunities for the women’s health and sexual health markets. This week we take a look at menopause.

In troubling economic times we can look to sexual health and women’s health as a beacon of hope

Fortunately, as many industries face difficult decisions ahead of an impending recession, two industries have proven to be recession-resistant: healthcare and sex.

Underserved Market: Abortion Access

Amboy Street Ventures’ Underserved Market series breaks down the history, developments and opportunities for the women’s health and sexual health markets. This week we take a look at abortion access.

Underserved Market: LGBTQ+ Health

Amboy Street Ventures’ Underserved Market series breaks down the history, developments and opportunities for the women’s health and sexual health markets. Here’s another long ignored vertical that we have our eyes on: LGBTQ+ Health.

Underserved Market: Menstruation and Hormonal Health

The Underserved Opportunity – Sexual Health and Women’s Health Overview

VCs love big bets. Today we can confidently take them in sexual health and women’s health, as the space shifts from vice or niche to mainstream.

Amboy Street Ventures invests $1m in Aunt Flow

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Aunt Flow to support the company’s plans to make free, 100% organic cotton period products available in every restroom, changing the world one cycle at a time.

ASV Insights – Top 10 Deals of 2021: Queen V and the trend of CPG conglomerates seeking innovation through acquisition

This week we look at companies in women’s health and sexual health that have been acquired by CPG conglomerates.

Amboy Street Ventures invests $1m in Contraline

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Contraline, to enable the brand to conduct what is believed to be the first clinical trial on a non-hormonal male contraceptive device in over 20 years with its innovation ADAM™. The trial will launch the next generation of non-hormonal male contraceptives, increasing choice for men and achieving public health impact.